Hutch News
Results per Page:
New Science Spotlight Articles
Every month, Fred Hutch postdoc writer/editors summarize two papers from each of our scientific divisions to stimulate collaborations across campus
September 25, 2023
Nanotech turns pro-tumor immune cells into cancer-killing triple agents
Strategy doubles survival in mice with cancer
Special delivery: Gold nanoparticles ship CRISPR cargo
Fred Hutch scientists used their new golden courier to edit genes tied to HIV, genetic blood disorders
Could gold be the key to making gene therapy for HIV and other blood disorders more accessible?
A proof-of-principle study published in Nature Materials shows that gold nanoparticles loaded with CRISPR and other gene-editing tools safely and effectively edited blood stem cells. (Photos, diagram available for media use.)
Improving cancer vaccines with T-cell programming nanoparticles
Dr. Matthias Stephan receives grant to develop cancer vaccine–optimizing, TCR-programming nanotechnology
Nanoparticles open doors to cancer-fighting CAR T cells
Tiny liposome-based drug carriers make tumors more vulnerable to targeted immunotherapy
New nanoparticles make targeted, temporary gene therapy possible
‘Hit-and-run’ technology could improve immunotherapy and HIV cure research
Tiny tech reprograms immune cells to fight cancer
Nanoparticles turn immune cells into leukemia-fighting powerhouses while they’re still inside the body
Intel and Fred Hutchinson Cancer Research Center to Explore the Use of Nanotechnology Tools for Early Disease Detection
The Intel Raman Bioanalyzer System™ to help researchers understand the molecular differences between healthy cells and diseased cells for better diagnostic methods